Anticipate generic drug launch
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Find generic entry opportunities
Proactively manage your pharmacy inventory
Manage your formulary budget
Drug patents …
… from Kazakhstan to Kalamazoo
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
|Title:||Synthesis of 3-[4-(2-aminoethoxy)-benzoyl]-2-aryl-6-hydroxybenzo[b]thiophenes|
|Abstract:||The present invention is directed to chemical processes for preparing 2-aryl-6-hydroxy-3-[4-(2-aminoethoxy)benzoyl]benzo[b]-thiophenes. The present invention is also directed to crystalline solvates and a non-solvated crystalline form of 6-hydroxy-2-(4-hydroxyphenyl)-3-[4-(2-piperidinoethoxy)benzoyl]-benzo[b]th iophene hydrochloride, as well as processes for their preparation.|
|Inventor(s):||LaBell; Elizabeth Smith (Lafayette, IN), McGill; John McNeill (Lafayette, IN), Miller; Randal Scot (Lafayette, IN)|
|Assignee:||Eli Lilly and Company (Indianapolis, IN)|
|Filing Date:||Jun 06, 1995|
|Claims:||1. A process for preparing a crystalline solvate of a compound of the formula: ##STR14## |
a) acylating a benzothiophene of the formula: ##STR15##
R.sup.4 is C.sub.1 -C.sub.4 alkoxy; and
R.sup.5 is C.sub.1 -C.sub.4 alkyl;
with an acylating agent of the formula: ##STR16##
R.sup.6 is chloro, bromo, or hydroxyl;
in the presence of a solvent and boron trichloride;
b) dealkylating the acylated benzothiophene by reacting said acylated benzothiophene with additional boron trichloride to prepare a compound of the formula: ##STR17##
c) isolating the crystalline solvate.
2. The process of claim 1 wherein R.sup.6 is chloro.
3. The process of claim 2 wherein R.sup.4 is methoxy and R.sup.5 is methyl.
4. The process of claim 3 wherein the acylation is conducted in the presence of 2-5 molar equivalents of BCl.sub.3.
5. The process of claim 3 wherein the dealkylation is conducted in the presence of 3-10 molar equivalents of BCl.sub.3.
6. The process of claim 3 where in the solvent is 1,2-dichlorethane.
7. A process for preparing a crystalline solvate of the formula: ##STR18##
which comprises the process of claim 1 wherein the solvent is 1,2,3-trichloropropane and which further comprises the step of adding methanol to the product mixture of step b) prior to isolating the crystalline solvate.
8. The process of claim 7 wherein R.sup.4 is methoxy, and R.sup.5 is methyl.
9. A process for preparing a crystalline solvate of the formula: ##STR19##
which comprises the process of claim 1 wherein the solvent is 1,2-dichloroethane and which further comprises the step of adding methanol to the product mixture of step b) prior to isolating the crystalline solvate.
10. The process of claim 9 wherein R.sup.4 is methoxy, and R.sup.5 is methyl.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.